CEOi Applauds New $100 Million Global Dementia Discovery Fund

Geneva, Switzerland – Following is a statement by George Vradenburg, convener of the Global CEO Initiative (CEOi) on Alzheimer’s Disease, on today’s announcement by UK Health Secretary Jeremy Hunt that more than $100 million has been raised to support the Dementia Discovery Fund.  The fund, which was created by the British government, is unique because it is bringing together government and industry to focus on a single disease – dementia.

Global CEO Initiative on Alzheimer’s Disease (CEOi) Launches Program to Harness Power of Big Data, Accelerating Pace of Alzheimer’s Research

Health care research and innovation collaborative Optum Labs selected as primary research partner

Washington, DC – The Global CEO Initiative on Alzheimer’s Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and innovation to public and private research agendas aimed at redefining care delivery and changing the way future generations are affected by Alzheimer’s disease.

CEOi Applauds Prime Minister Cameron’s Bold Action On Dementia

Washington, DC – UK Prime Minister David Cameron announced new plans on Saturday to tackle dementia in the “The Prime Minister’s Challenge on Dementia 2020,” the UK Government’s bold dementia agenda for the next five years.  The Challenge envisions that by 2020 England will be the global leader in dementia care and research related to dementia and other neurodegenerative diseases.  The Government will spend 3 million pounds (US $4.6 million) on dementia research, train all Nati

Pages

Latest from the Newsroom

January 26, 2018
The Global CEO Initiative on Alzheimer’s Disease released “Progress and Challenges in Alzheimer’s Disease Drug Development:  An Update on Scientific, Clinical and Regulatory Considerations from an Industry Perspective.”  This paper provides an update to the 2016 paper and provides recommendations to increase the speed of drug development for those impacted by Alzheimer’s disease.
November 8, 2016
Last week, global stakeholders convened for the third annual Lausanne Workshop to identify, address and overcome barriers on the road to stopping Alzheimer’s by 2025. Alzheimer’s experts from government, industry, patient advocacy, regulation, public policy and academia learned lessons from those closest to Alzheimer’s disease as well as experts in other disease areas. Their goal was to challenge traditional approaches to care, drug development, regulatory and market access issues.

Latest from theBlog

July 5, 2013
By: Jan Dougherty Director of Family and Community Services Banner Alzheimer's Institute With 10,000 adults turning 65 each day, boomers are the most active generation we have seen in our lifetime. However, as our population ages, many can't help but worry if a "senior moment" might actually be something worse.